Antibodies are becoming popular in the clinical practice for their use in the treatment of variety of clinical conditions such as cardiovascular and infectious diseases, autoimmune and CNS disorders, cancer and inflammation. Owing to their stable nature and high affinity for variety of biomolecules, antibodies are considered as best targeting and diagnostic reagents. In order to show their effects antibodies need to interact with elements of immune system and initiate the reaction cascade. ... Read more

High rate of product approvals, combined with rising adoption of therapeutic antibodies in developing economies is positively influencing the growth of the global antibodies market, with total revenues expected to surpass US$ 105 Bn in 2016. Approval of monoclonal antibody products, including therapeutic antibodies, drug conjugates, and antibody fragments in key markets of the U.S., Europe, and ... Read more